Keyphrases
Androgen Receptor
100%
Castration-resistant Prostate Cancer
100%
Monoamine Oxidase A (MAO-A)
100%
Hormone-dependent
100%
Prostate Cancer
40%
Yes-associated Protein 1 (YAP1)
20%
Receptor-ligand Interaction
10%
Molecular Mechanism
10%
Therapeutic Strategies
10%
Growth Inhibition
10%
Receptor-mediated
10%
Monoamine Neurotransmitters
10%
Pharmacologic
10%
Cancer Growth
10%
Receptor Binding
10%
Co-target
10%
Mitochondrial Enzymes
10%
Regulatory Circuit
10%
Transcriptional Activity
10%
Androgen Signaling
10%
Prostate Cancer Development
10%
Dietary Amines
10%
Androgens
10%
Enzalutamide
10%
Androgen-independent
10%
Inhibition Efficacy
10%
Monoamine Oxidase A Gene
10%
YAP1 Signaling
10%
Androgen Response Element
10%
Castration-resistant Prostate Cancer Cells
10%
Darolutamide
10%
Oncogenic Drivers
10%
Apalutamide
10%
Medicine and Dentistry
Androgen Receptor
100%
Amine Oxidase (Flavin Containing) Isoenzyme A
100%
Castration Resistant Prostate Cancer
100%
Prostate Cancer
45%
Androgen
27%
Upregulation
9%
Growth Inhibition
9%
Cancer Cell
9%
Receptor Binding
9%
Growth, Development and Aging
9%
DNA Responsive Element
9%
Mitochondrial Enzyme
9%
Monoamine Neurotransmitter
9%
Enzalutamide
9%
Pharmacology, Toxicology and Pharmaceutical Science
Androgen Receptor
100%
Amine Oxidase (Flavin Containing) Isoenzyme A
100%
Castration Resistant Prostate Cancer
100%
Prostate Cancer
45%
Androgen
27%
Neurotransmitter
9%
Monoamine
9%
Mitochondrial Enzyme
9%
Enzalutamide
9%
Biochemistry, Genetics and Molecular Biology
Androgen Receptor
100%
Monoamine Oxidase A
100%
YAP1
27%
Genetics
9%
Upregulation
9%
Cancer Cell
9%
Enzyme
9%
Monoamine Neurotransmitter
9%
Growth, Development and Aging
9%
Response Element
9%
Growth Inhibition
9%
Enzalutamide
9%
Receptor Binding
9%